Dr. Karen Mitchell

Senior Director - Clinical Operations

you@email.com · (212) 555-0824 · New York, United States linkedin.com/in/repolish-ai

Executive Summary

Healthcare administrator with 10+ years of experience in pharmaceutical operations, clinical program management, and regulatory compliance. Expertise in driving operational excellence across global clinical trials, managing multi-million dollar budgets, and leading cross-functional teams in a regulated environment.

Core Competencies

• Strategic Thinking · Leadership · Cross-functional Collaboration · Communication
• Clinical Trial Management · Regulatory Compliance · Budget Management · Data Analysis

Leadership Experience

Senior Director - Clinical Operations

Pfizer · 2020-04 – Present · New York

• Led global clinical operations for a $2B therapeutic area portfolio, overseeing 25+ active clinical trials across 30 countries with 8,000+ enrolled patients.
• Directed operational strategy for 3 pivotal Phase III studies that supported FDA and EMA regulatory submissions resulting in 2 new drug approvals.
• Managed a $150M annual operational budget, implementing vendor consolidation that reduced CRO costs by 22% while improving site startup timelines by 35%.
• Built and led a team of 15 clinical operations managers, establishing standardized processes that improved inspection readiness scores from 82% to 98%.

Clinical Operations Manager

Johnson & Johnson · 2015-06 – 2020-03 · New Brunswick

• Managed 10+ Phase I-IV clinical trials in immunology and oncology, overseeing site selection, patient enrollment, and data collection across North America and Europe.
• Implemented a risk-based monitoring approach that reduced data query rates by 40% and monitoring costs by 25%.
• Led the integration of electronic data capture (EDC) systems across the therapeutic area, improving data lock timelines by 45%.

Education

• Dr.P.H. in Health Policy & Management, Johns Hopkins University (2011-08 – 2015-05) — GPA: 3.9
• M.P.H. in Healthcare Administration, University of North Carolina at Chapel Hill (2009-08 – 2011-05) — GPA: 4.0
• B.S. in Biology & Public Policy, Duke University (2005-08 – 2009-05) — GPA: 3.8

Publications

• Mitchell, K. et al. "Operational Excellence in Global Clinical Trials" - Drug Discovery Today (2024)
• Mitchell, K. "Risk-Based Monitoring: A Practical Framework" - Clinical Researcher (2023)

Speaking

• DIA Global Annual Meeting 2024 - "Building Resilient Clinical Operations"
• Clinical Operations in Pharma Summit 2023 - "Vendor Partnership Strategies"

Board

• Advisory Board Member, Duke University Health Policy Program
• Board Member, Clinical Research Forum